Choice of medical therapy to lower triglycerides in those at risk of pancreatitis

    loading  Checking for direct PDF access through Ovid

Excerpt

The relationship between triglyceride levels and cardiovascular risk remains complex with large, high-quality epidemiological studies indicating that triglyceride levels do not predict risk beyond other lipids and usual classical risk factors [1], whereas studies of genetic polymorphisms suggest that triglycerides-related pathways may indeed have a causal factor [2]. Statin therapy remains first-line therapy for cardiovascular risk reduction regardless of triglyceride levels [3].

Related Topics

    loading  Loading Related Articles